Investigations, CAPA & Trending in Aseptic Process Failures

Regulatory Expectations for Aseptic Failure Management in FDA and MHRA Audits

Regulatory Expectations for Aseptic Failure Management in FDA and MHRA Audits Regulatory Expectations for Aseptic Failure Management in FDA and MHRA Audits Aseptic processing is a critical area within the pharmaceutical sector, where stringent regulatory standards are mandated to ensure product sterility and safety. When managing aseptic failure incidents, regulators like the FDA and the MHRA have specific expectations for…

Continue Reading Regulatory Expectations for Aseptic Failure Management in FDA and MHRA Audits

Escalation Processes for Repeat Aseptic Failures, EM Trends and Media Fill Issues

Escalation Processes for Repeat Aseptic Failures, EM Trends and Media Fill Issues In the pharmaceutical industry, ensuring the sterility and integrity of aseptic processes is paramount. However, when aseptic failures recur, it becomes essential to adopt a systematic approach to manage these situations effectively. This article outlines the regulatory expectations and best practices for escalation processes related to repeat aseptic…

Continue Reading Escalation Processes for Repeat Aseptic Failures, EM Trends and Media Fill Issues

Global Harmonisation of Aseptic Investigation and CAPA Templates Across Sites

Global Harmonisation of Aseptic Investigation and CAPA Templates Across Sites Global Harmonisation of Aseptic Investigation and CAPA Templates Across Sites In the context of pharmaceutical manufacturing, particularly within aseptic processing, ensuring compliance with regulatory expectations is crucial. The regulatory frameworks by the US FDA, EMA, MHRA, and PIC/S emphasize the need for stringent validation processes. This article explores the harmonisation…

Continue Reading Global Harmonisation of Aseptic Investigation and CAPA Templates Across Sites

Using CCS Reviews to Drive CAPA Prioritisation and Aseptic Risk Reduction

Using CCS Reviews to Drive CAPA Prioritisation and Aseptic Risk Reduction In the realm of pharmaceutical manufacturing and quality assurance, ensuring the sterility and safety of products is paramount. The integration of Corrective and Preventive Action (CAPA) systems and Change Control Systems (CCS) plays a crucial role in maintaining compliance with regulatory expectations. This article aims to elucidate the function…

Continue Reading Using CCS Reviews to Drive CAPA Prioritisation and Aseptic Risk Reduction

Building Competency in Aseptic Failure Investigations Training and Coaching Programs

Building Competency in Aseptic Failure Investigations Training and Coaching Programs Building Competency in Aseptic Failure Investigations Training and Coaching Programs Aseptic processing is a critical component in the pharmaceutical industry, ensuring that products are manufactured in a manner that prevents contamination. In this article, we will outline a step-by-step guide on developing effective training programs aimed at aseptic investigation teams….

Continue Reading Building Competency in Aseptic Failure Investigations Training and Coaching Programs

Case Studies of Poorly Managed Aseptic Failures and Lessons Learned

Case Studies of Poorly Managed Aseptic Failures and Lessons Learned Case Studies of Poorly Managed Aseptic Failures and Lessons Learned Aseptic processing is crucial in the pharmaceutical industry, particularly for the manufacturing of sterile products. Any lapse in aseptic technique can have dire consequences, leading to contamination, failed inspections, and regulatory action. This article will present step-by-step tutorials detailing case…

Continue Reading Case Studies of Poorly Managed Aseptic Failures and Lessons Learned

Inspection Ready Evidence Packs for Aseptic Failure Investigations and CAPA

Inspection Ready Evidence Packs for Aseptic Failure Investigations and CAPA Inspection Ready Evidence Packs for Aseptic Failure Investigations and CAPA The pharmaceutical industry is governed by stringent regulations to ensure the safety and efficacy of products. Aseptic processing, essential in the manufacturing of sterile products, is particularly scrutinized during inspections. When a sterility failure occurs, conducting thorough investigations and creating…

Continue Reading Inspection Ready Evidence Packs for Aseptic Failure Investigations and CAPA

Sponsor and CMO Interface for Aseptic Investigations and CAPA Oversight

Sponsor and CMO Interface for Aseptic Investigations and CAPA Oversight Sponsor and CMO Interface for Aseptic Investigations and CAPA Oversight The robust and regulatory-compliant oversight of aseptic processing is a cornerstone of pharmaceutical quality assurance. Aseptic failures, which represent significant risks to product sterility and integrity, necessitate stringent oversight and well-defined responsibilities among sponsors and Contract Manufacturing Organizations (CMOs). This…

Continue Reading Sponsor and CMO Interface for Aseptic Investigations and CAPA Oversight

Quality Metrics and Dashboards for Aseptic Deviations, EM Excursions and CAPA

Quality Metrics and Dashboards for Aseptic Deviations, EM Excursions and CAPA Understanding Regulatory Expectations in Aseptic Processing The pharmaceutical industry is governed by an extensive set of regulations aimed at ensuring product quality and patient safety. In this context, understanding validation in aseptic processing is critical for compliance with regulatory agencies such as the US FDA, EMA, and MHRA. The…

Continue Reading Quality Metrics and Dashboards for Aseptic Deviations, EM Excursions and CAPA